Identifying Digital Endpoints to Assess Fatigue, Sleep and Activities of Daily Living in Neurodegenerative Disorders and Immune-mediated Inflammatory Diseases


The IDEA-FAST project is a 5-year IMI2 project under Call H2020-JTI-IMI2-2018-15-two-stage – digital endpoints in neurodegenerative and immune-mediated diseases (total budget €42 Million) that starts in Februrary 2020. IDEA-FAST aims to identify digital endpoints that provide reliable, objective and sensitive evaluation of activities of daily life …


The IDEA-FAST consortium consists of 46 partners across Europe and the U.S.


For patients with chronic diseases such as neurodegenerative disorders (NDD) and immune-mediated inflammatory diseases (IMID), a key attribute for any successful therapeutic intervention is its ability to improve the patients’ activities of daily living (ADL) and health-related quality of life (HRQoL).

Latest News

Press Release

Newcastle upon Tyne, February 05, 2019 – A new European research project to Identify Digital Endpoints to Assess FAtigue, Sleep and acTivities of daily living (acronym: IDEA-FAST) in the following neurodegenerative disorders (NDD): Parkinson’s disease and Huntington’s disease and in […]

Upcoming Events

Twitter Feed

3 weeks ago
Successful first day at the IDEA-FAST kick-off meeting. Big thank you for organising this event and making this possible! @UniofNewcastle @IMI_JU @EU_H2020 @EFPIA @ParkinsonsUK
1 month ago
The IDEA-FAST project is ready for Kick-Off.
February 2020, Newcastle UK

More information about the project: